NT-pro-BNP, but not C-reactive protein, is predictive of atrial fibrillation in patients undergoing coronary artery bypass surgery

European Journal of Cardio-thoracic Surgery

Volumn 37, Issue 1, 2010, Pages 100-105

  Gasparovic, Hrvoje ^a   Burcar, Ivan ^a   Kopjar, Tomislav ^a   Vojkovic, Jakov ^a   Gabelica, Rajka ^a   Biocina, Bojan ^a   Jelic, Ivan ^a  

^a KBC Zagreb   (Croatia)

Author keywords

Atrial fibrillation; Coronary artery bypass

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; LACTIC ACID; TROPONIN T;

AGE; AMINO TERMINAL SEQUENCE; ARTICLE; CORONARY ARTERY BYPASS SURGERY; HEART ATRIUM FIBRILLATION; HEART MUSCLE REVASCULARIZATION; PRIORITY JOURNAL; SINUS RHYTHM; TISSUE LEVEL; TRANSCORONARY LACTATE GRADIENT;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 72749118544     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.07.003     Document Type: Article

References (24)

1. Magee M.J., Herbert M.A., Dewey T.M., Edgerton J.R., Ryan W.H., Prince S., and Mack M.J. Atrial fibrillation after coronary artery bypass grafting surgery: development of a predictive risk algorithm. Ann Thorac Surg 83 (2007) 1707-1712
2. Budeus M., Feindt P., Gams E., Wieneke H., Sack S., Erbel R., and Perings C. b-Blocker prophylaxis for atrial fibrillation after coronary artery bypass grafting in patients with sympathovagal imbalance. Ann Thorac Surg 84 (2007) 61-66
3. Zaman A.G., Archbold A., Helft G., Paul E.A., Curzen N.P., and Mills P.G. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation 101 (2000) 1403-1408
4. Patti G., Chello M., Candura D., Pasceri V., D'Ambrosio A., Covino E., and Di Sciascio G. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (atorvastatin for reduction of myocardial dysrhythmia after cardiac surgery) study. Circulation 114 (2006) 1455-1461
5. Ducceschi V., D'Andrea A., Liccardo B., Alfieri A., Sarubbi B., De Feo M., Santangelo L., and Cotrufo M. Perioperative clinical predictors of atrial fibrillation occurrence following coronary artery surgery. Eur J Cardiothorac Surg 16 (1999) 435-439
6. Bakir I., Casselman F.P., Brugada P., Geelen P., Wellens F., Degrieck I., Van Praet F., Vermeulen Y., De Geest R., and Vanermen H. Current strategies in the surgical treatment of atrial fibrillation: review of the literature and Onze Lieve Vrouw clinic's strategy. Ann Thorac Surg 83 (2007) 331-340
7. Ahlsson A.J., Bodin L., Lundblad O.H., and Englund A.G. Postoperative atrial fibrillation is not correlated to C-reactive protein. Ann Thorac Surg 83 (2007) 1332-1337
8. Kangasniemi O.P., Biancari F., Luukkonen J., Vuorisalo S., Satta J., Pokela R., and Juvonen T. Preoperative C-reactive protein is predictive of long-term outcome after coronary artery bypass surgery. Eur J Cardiothorac Surg 29 (2006) 983-985
9. Braunwald E. Biomarkers in heart failure. N Engl J Med 358 (2008) 2148-2159
10. Kolvekar S., D'Souza A., Akhtar P., Reek C., Garratt C., and Spyt T. Role of atrial ischaemia in development of atrial fibrillation following coronary artery bypass surgery. Eur J Cardiothorac Surg 11 (1997) 70-75
11. Onorati F., Cristodoro L., Caroleo S., Esposito A., Amantea B., Santangelo E., and Renzulli A. Troponin I and lactate from coronary sinus predict cardiac complications after myocardial revascularization. Ann Thorac Surg 83 (2007) 1016-1023
12. Vitek V., and Cowley R.A. Blood lactate in the prognosis of various forms of shock. Ann Surg 173 (1971) 308-331
13. Basaran M., Sever K., Kafali E., Ugurlucan M., Sayin O.A., Tansel T., Alpagut U., Dayioglu E., and Onursal E. Serum lactate level has prognostic significance after pediatric cardiac surgery. J Cardiothorac Vasc Anesth 20 (2006) 43-47
14. Hannan R.L., Ybarra M.A., White J.A., Ojito J.W., Rossi A.F., and Burke R.P. Patterns of lactate values after congenital heart surgery and timing of cardiopulmonary support. Ann Thorac Surg 80 (2005) 1468-1473
15. Rao V., Ivanov J., Weisel R.D., Cohen G., Borger M.A., and Mickle D.A. Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery. Ann Thorac Surg 71 (2001) 1925-1930
16. Antman E.M., and Braunwald E. In: Libby P., Bonow R.O., Mann D.L., and Zipes D.P. (Eds). Braunwald's heart disease. A textbook of cadiovascular medicine. 8th edition (2008), Saunders Elsevier, Philadelphia, PA 1226
17. Kragelund C., Gronning B., Kober L., Hildebrandt P., and Steffensen R. N-terminal Pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352 (2005) 666-675
18. Ascione R., Caputo M., Calori G., Lloyd C.T., Underwood M.J., and Angelini G.D. Predictors of atrial fibrillation after conventional and beating heart coronary surgery: a prospective, randomized study. Circulation 102 (2000) 1530-1535
19. Mariscalco G., Lorusso R., Klersy C., Ferrarese S., Tozzi M., Vanoli D., Domenico B.V., and Sala A. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg 84 (2007) 1158-1164
20. Bradley D., Creswell L.L., Hogue Jr. C.W., Epstein A.E., Prystowsky E.N., Daoud E.G., and American College of Chest Physicians. Pharmacologic prophylaxis: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 128 (2005) 39S-47S
21. Paraskevas K.I. Applications of statins in cardiothoracic surgery: more than just lipid-lowering. Eur J Cardiothorac Surg 33 (2008) 377-390
22. Kourliouros A., De Souza A., Roberts N., Marciniak A., Tsiouris A., Valencia O., Camm J., and Jahangiri M. Dose-related effect of statins on atrial fibrillation after cardiac surgery. Ann Thorac Surg 85 (2008) 1515-1520
23. Shelton R.J., Clark A.L., Goode K., Rigby A.S., and Cleland J.G.F. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Eur Heart J 27 (2006) 2353-2361
24. Lo B., Fijnheer R., Nierich A.P., Bruins P., and Kalkman C.J. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg 79 (2005) 1530-1535